Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Day One Biopharmaceuticals, Inc. (DAWN) had Free Cash Flow per Share of $-0.58 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$30.76M |
|
$-36.00M |
|
$2.88M |
|
$27.88M |
|
$71.83M |
|
$-41.07M |
|
$5.07M |
|
$-36.00M |
|
$-36.00M |
|
$-36.00M |
|
$-36.00M |
|
$-36.00M |
|
$-36.00M |
|
$-41.07M |
|
$-40.17M |
|
102.71M |
|
102.71M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$508.65M |
|
$2.51M |
|
$25.70M |
|
$534.36M |
|
$47.88M |
|
-- |
|
$6.96M |
|
$54.84M |
|
$479.51M |
|
$459.11M |
|
$479.51M |
|
101.35M |
|
| Cash Flow Statement Financials | |
$-59.00M |
|
$-32.61M |
|
$0.00M |
|
$124.97M |
|
$33.36M |
|
$-91.61M |
|
$12.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
90.62% |
|
-133.50% |
|
-133.50% |
|
-- |
|
-117.02% |
|
-117.02% |
|
$-59.31M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.81 |
|
1.70 |
|
52.82 |
|
-7.51% |
|
-7.84% |
|
-6.74% |
|
-7.51% |
|
$4.73 |
|
|
Free Cash Flow per Share |
$-0.58 |
$-0.57 |
|